Evidence map›Paper›PMID 40256042›Full record

ArticleOpen forum infectious diseases2025

Mohsen Meidani, Maryam Moradi, Mehrzad Rahmanian, Mehrdad Salehi, Morteza Foroumandi, Farnoosh Larti, Neda Alijani, Hanieh Movahhed, Ensiyeh Rahimi, Fereshteh Ghiasvand

Abstract read
In one paragraph

Article in Open forum infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Mohsen MeidaniDepartment of Infectious Diseases, School of Medicine, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
Maryam MoradiEye Research Center, the Five Senses Health Institute, Rassoul Akram Hospital Iran University of Medical Sciences, Tehran, Iran.ORCID https://orcid.org/0000-0003-3675-0500
Mehrzad RahmanianDepartment of Cardiothoracic Surgery, School of Medicine, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
Mehrdad SalehiDepartment of Cardiothoracic Surgery, School of Medicine, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
Morteza ForoumandiDepartment of Critical Care Medicine, School of Medicine, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
Farnoosh LartiDepartment of Cardiology, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.ORCID https://orcid.org/0000-0001-7939-9306
Neda AlijaniDepartment of Infectious Disease and Tropical Medicine, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Hanieh MovahhedSchool of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Ensiyeh RahimiDepartment of Infectious Diseases, School of Medicine, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.ORCID https://orcid.org/0000-0002-3332-2378
Fereshteh GhiasvandDepartment of Infectious Diseases, School of Medicine, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Fungal endocarditis is a very uncommon and deadly illness that causes inflammation in the heart's lining, including the valves. Case Report: In this article, we describe a case of recurrent aortic-valve Discussion: Early recognition in patients with underlying immunosuppressive conditions and immunocompetent hosts is critical to decreasing the mortality rate. Aspergillosis must be considered in every patient with a prior valve replacement history and culture-negative endocarditis. Surgical debridement and appropriate antifungal agents are required to resolve the problem.

Indexed as

Aspergillus endocarditisendocarditisimmunocompetencyrecurrent aspergillusspondylodiscitis

Identifiers

PMID40256042
PMCPMC12006791

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.